News

Topics span the application of optical genome mapping (OGM) in research applications in cancer, cell and gene therapy, and genetic diseases SAN DIEGO, Jan. 19, 2024 (GLOBE NEWSWIRE) -- Bionano ...
A sponsored session will feature Dr. Lucia Gallego Villarejo from Ruhr University Bochum, Dr. Jeanne Loring from Scripps Research Institute, and Dr. Alicia Bertolotti from Bionano presenting on ...
Three peer-reviewed publications collectively illustrate the building support for optical genome mapping (OGM) as a tool for cell and gene therapy development that allows researchers in academic ...
SAN DIEGO, Aug. 30, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced a publication in Nature Communications demonstrating the utility of optical genome mapping (OGM ...
--Bionano Genomics, Inc. today announced its ... Annual Meeting and Expo with a broad range of content covering the utility of optical genome mapping for cell and gene therapy and ...
Bionano Announces Publication Showing that OGM Identifies Variant that Indicates Use of Proven Therapy in Acute Promyelocytic Leukemia Jan. 07, 2025 8:00 AM ET Bionano Genomics, Inc. (BNGO) ...
(2024-05-21 | NDAQ:BNGO) Bionano Announces Three Publications Demonstrating OGM's Utility for Cell and Gene Therapy ... Bionano Announces Three Publications Demonstrating OGM's Utility for Cell and ...
--Bionano Genomics, Inc. today announced its participation in the International Society for Stem Cell Research Annual Meeting 2024 with a broad range of content covering the utility of optical ...
A sponsored session will feature Dr. Alex Hastie from Bionano, Dr. Suk See De Ravin from National Institute of Health (NIH) and Travis Hardcastle from Synthego presenting on the utility of optical ...
A sponsored session will feature Dr. Alex Hastie from Bionano, Dr. Suk See De Ravin from National Institute of Health (NIH) and Travis Hardcastle from Synthego presenting on the utility of optical ...
A sponsored session will feature Dr. Alex Hastie from Bionano, Dr. Suk See De Ravin from National Institute of Health (NIH) and Travis Hardcastle from Synthego presenting on the utility of optical ...